首页> 外文期刊>International journal of clinical pharmacy. >Implementation fidelity of a clinical medication review intervention: process evaluation
【24h】

Implementation fidelity of a clinical medication review intervention: process evaluation

机译:临床药物审查干预的实施保真性:过程评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background Implementation of clinical medication reviews in daily practice is scarcely evaluated. The Opti-Med intervention applied a structured approach with external expert teams (pharmacist and physician) to conduct medication reviews. The intervention was effective with respect to resolving drug related problems, but did not improve quality of life. Objective The objective of this process evaluation was to gain more insight into the implementation fidelity of the intervention. Setting Process evaluation alongside a cluster randomized trial in 22 general practices and 518 patients of 65 years and over. Method A mixed methods design using quantitative and qualitative data and the conceptual framework for implementation fidelity was used. Implementation fidelity is defined as the degree to which the various components of an intervention are delivered as intended. Main outcome measure Implementation fidelity for key components of the Opti-Med intervention. Results Patient selection and preparation of the medication analyses were carried out as planned, although mostly by the Opti-Med researchers instead of practice nurses. Medication analyses by expert teams were performed as planned, as well as patient consultations and patient involvement. 48% of the proposed changes in the medication regime were implemented. Cooperation between expert teams members and the use of an online decision-support medication evaluation facilitated implementation. Barriers for implementation were time constraints in daily practice, software, difficulties with patient selection and incompleteness of medical files. The degree of embedding of the intervention was found to influence implementation fidelity. The total time investment for healthcare professionals was 94 min per patient. Conclusion Overall, the implementation fidelity was moderate to high for all key components of the Opti-Med intervention. The absence of its effectiveness with respect to quality of life could not be explained by insufficient implementation fidelity.
机译:背景技术几乎可以评估日常实践中临床药物治疗评论的实施。 Opti-Med干预使用外部专家团队(药剂师和医生)的结构化方法来进行药物评论。干预对于解决毒品相关问题是有效的,但没有提高生活质量。目的对这个过程评估的目的是更有了解干预的实施保真程度。在22项一般实践和518名65岁患者和超过518名65岁患者的群集随机试验方面设定过程评估。方法使用定量和定性数据的混合方法设计和实现保真度的概念框架。实施保真度被定义为介入的各种组件的程度如预期交付。主要结果衡量Opti-Med干预的关键组成部分的实施保真度。结果患者选择和制备药物分析按计划进行,但主要由Opti-Med研究人员而不是练习护士。专家组的药物分析是按计划进行的,以及患者咨询和患者参与。实施了48%的药物制度改变。专家团队成员之间的合作以及在线决策支持药物评​​估促进实施。实施障碍是日常实践,软件,患者选择和医疗文件不完整的困难时的时间限制。发现干预的嵌入程度会影响实施保真度。医疗保健专业人员的总投资每位患者为94分钟。结论总体而言,实现保真度适用于Opti-Med干预的所有关键部件的高度至高。无法通过不足的实施保真度来解释缺乏生命质量的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号